Results 241 to 250 of about 8,503,937 (347)
Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia. [PDF]
Palmiero P+4 more
europepmc +1 more source
Political changes and trends in cardiovascular risk factors in the Czech Republic, 1985-92. [PDF]
Martin Bobák+4 more
openalex +1 more source
This study constructs a stacked multimodal machine learning model for nonalcoholic fattly liver disease (NAFLD) by integrating genetic and clinical features, and synthesize an in‐silico quantitative marker (ISNLD) that enables personalized risk stratification for intrahepatic and extrahepatic outcomes of high‐risk individuals of NAFLD.
Lushan Xiao+14 more
wiley +1 more source
Can Cardiovascular Risk Factors Be Predicted? The Case of Weight-Adjusted Waist Index. [PDF]
Borghi C, Fiorini G.
europepmc +1 more source
Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension [PDF]
W WHITE
openalex +1 more source
This study identifies alnustone, a natural compound from Alpinia katsumadai, as a potent therapeutic agent for MASLD and MASH. Alnustone enhances mitochondrial fatty acid β‐oxidation by directly targeting calmodulin, improving liver steatosis, fibrosis, and insulin resistance in vivo.
Shourui Hu+13 more
wiley +1 more source
Microplastics and Nanoplastics: The Next Frontier of Cardiovascular Risk? [PDF]
O' Dowling R.
europepmc +1 more source
Cardiovascular Risk Factors and Blood Pressure Control in Continuous Ambulatory Peritoneal Dialysis
Norbert Lameire
openalex +1 more source
In the context of chronic hyperglycemia, a DDR is initiated, leading to the pathological activation of DNA‐PKcs in the diabetic heart. This activated DNA‐PKcs directly interacts with and phosphorylates YAP1 at Thr226, thereby increasing the nuclear expression of YAP1.
Junyan Wang+10 more
wiley +1 more source
Lipoprotein (a) – Current status in the UK
S. Ansari, D. Neely, J. Payne, J. Cegla
doaj